Key result
Combined Tbx3 and Tbx5 deficiency in mice triggers conduction defects and elevates VT susceptibility.
Why the study?
TBX3 and TBX5 are required for cardiac conduction system development and linked to human conduction diseases, but their coordinated role in the ventricular conduction system was not evaluated.
Does conditional deletion of Tbx3 and Tbx5 alter the molecular fate and function of the adult ventricular conduction system in mice?
Does conditional deletion of Tbx3 and Tbx5 alter the molecular fate and function of the adult ventricular conduction system in mice?
Tbx3 and Tbx5 are essential for maintaining the molecular identity and electrophysiological function of the adult ventricular conduction system.
Findings remain preclinical; extends Tbx3/Tbx5 roles from development to adult murine conduction maintenance.
The cardiac conduction system (CCS) orchestrates the electrical impulses that enable coordinated contraction of the cardiac chambers. The T-box transcription factors TBX3 and TBX5 are required for CCS development and associated with overlapping and distinct human CCS diseases. We evaluated the coordinated role of Tbx3 and Tbx5 in the murine ventricular conduction system (VCS). We engineered a compound Tbx3:Tbx5 conditional knockout allele for both genes located in cis on mouse chromosome 5. Conditional deletion of both T-box transcriptional factors in the VCS, using the VCS-specific MinKCreERT2, caused loss of VCS function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the adult VCS led to conduction defects, including prolonged PR and QRS intervals and elevated susceptibility to ventricular tachycardia. These electrophysiological defects occurred prior to detectable alterations in cardiac contractility or histologic morphology, indicative of a primary conduction system defect. Tbx3:Tbx5 double-knockout VCS cardiomyocytes revealed a transcriptional shift toward non-CCS-specialized working myocardium, indicating a change to their cellular identity. Furthermore, optical mapping revealed a loss of VCS-specific conduction system propagation. Collectively, these findings indicate that Tbx3 and Tbx5 coordinate to control VCS molecular fate and function, with implications for understanding cardiac conduction disorders in humans.
No takes yet. Share an insight, caveat, or question.
Burnicka-Turek et al. (2025) studied Cardiac conduction system function. Conditional deletion of Tbx3 and Tbx5 was evaluated on Ventricular conduction system function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the adult murine ventricular conduction system led to conduction defects, including prolonged PR and QRS intervals and elevated susceptibility to ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: